HOME › DRUGS › GANCICLOVIR
ACTIVE SUBSTANCE / INN

GANCICLOVIR

Brand name(s): VITRASERT, GANZYK-RTU, GANCICLOVIR, ZIRGAN, Vitrasert Implant, CYTOVENE
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
DISCONTINUED
NDA020460
ANDA076457
ACTIVE SUBSTANCE
Ganciclovir
REGULATORS
FDA · EMA
SPONSORS / MAH
EXELA PHARMA, BAUSCH AND LOMB, RANBAXY LABS LTD
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CYTOVENENDA020460ROCHE PALODiscontinued
ZIRGANNDA022211BAUSCH AND LOMBPrescription
GANZYK-RTUNDA209347EXELA PHARMADiscontinued
GANCICLOVIRANDA076457RANBAXY LABS LTDDiscontinued
VITRASERTNDA020569BAUSCH AND LOMBDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Vitrasert ImplantDr. Gerhard Mann, Chem.-Pharm. Fabrik GmbH..Withdrawn18/03/1997Cytomegalovirus Retinitis;HIV Infections

FULL INTELLIGENCE ON GANCICLOVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →